157 related articles for article (PubMed ID: 22867948)
1. Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome.
Jonsson MV; Theander E; Jonsson R
Presse Med; 2012 Sep; 41(9 Pt 2):e511-6. PubMed ID: 22867948
[TBL] [Abstract][Full Text] [Related]
2. Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome.
Sène D; Ismael S; Forien M; Charlotte F; Kaci R; Cacoub P; Diallo A; Dieudé P; Lioté F
Arthritis Rheumatol; 2018 Sep; 70(9):1481-1488. PubMed ID: 29669392
[TBL] [Abstract][Full Text] [Related]
3. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
4. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
Le Guern V; Mouthon L
Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
[TBL] [Abstract][Full Text] [Related]
5. Association between primary Sjögren's syndrome and non-Hodgkin's lymphoma.
Opriş D; Iosif CI; Predeţeanu D
Rom J Intern Med; 2004; 42(4):715-23. PubMed ID: 16366143
[TBL] [Abstract][Full Text] [Related]
6. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
[TBL] [Abstract][Full Text] [Related]
7. Mortality in Sjögren's syndrome.
Voulgarelis M; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2008; 26(5 Suppl 51):S66-71. PubMed ID: 19026146
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
Anaya JM; McGuff HS; Banks PM; Talal N
Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
[TBL] [Abstract][Full Text] [Related]
9. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
[TBL] [Abstract][Full Text] [Related]
10. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
[TBL] [Abstract][Full Text] [Related]
11. Lymphoma in Sjogren's syndrome.
Pavlidis NA; Drosos AA; Papadimitriou C; Talal N; Moutsopoulos HM
Med Pediatr Oncol; 1992; 20(4):279-83. PubMed ID: 1608349
[TBL] [Abstract][Full Text] [Related]
12. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
13. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome.
Voulgarelis M; Dafni UG; Isenberg DA; Moutsopoulos HM
Arthritis Rheum; 1999 Aug; 42(8):1765-72. PubMed ID: 10446879
[TBL] [Abstract][Full Text] [Related]
14. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
Nocturne G; Seror R; Fogel O; Belkhir R; Boudaoud S; Saraux A; Larroche C; Le Guern V; Gottenberg JE; Mariette X
Arthritis Rheumatol; 2015 Dec; 67(12):3226-33. PubMed ID: 26359802
[TBL] [Abstract][Full Text] [Related]
15. [Gougerot-Sjögren syndrome and malignant lymphoproliferative syndromes].
Grosbois B; Jego P; Leblay R
Rev Med Interne; 1998 May; 19(5):319-24. PubMed ID: 9775165
[TBL] [Abstract][Full Text] [Related]
16. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Ioannidis JP; Vassiliou VA; Moutsopoulos HM
Arthritis Rheum; 2002 Mar; 46(3):741-7. PubMed ID: 11920410
[TBL] [Abstract][Full Text] [Related]
18. Hematologic manifestations and predictors of lymphoma development in primary Sjögren syndrome: clinical and pathophysiologic aspects.
Baimpa E; Dahabreh IJ; Voulgarelis M; Moutsopoulos HM
Medicine (Baltimore); 2009 Sep; 88(5):284-293. PubMed ID: 19745687
[TBL] [Abstract][Full Text] [Related]
19. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
Nagai K
Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
[TBL] [Abstract][Full Text] [Related]
20. Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis.
Nishishinya MB; Pereda CA; Muñoz-Fernández S; Pego-Reigosa JM; Rúa-Figueroa I; Andreu JL; Fernández-Castro M; Rosas J; Loza Santamaría E
Rheumatol Int; 2015 Jan; 35(1):17-26. PubMed ID: 24899571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
